The Medical Technology (MedTech) sector is currently navigating a period of profound transformation, solidifying its position as one of Venture Capital's (VC) most compelling frontiers. This assessment is validated by a powerful convergence of factors: the massive and resilient growth of the global healthcare market, the accelerating technological disruption catalysed by Artificial Intelligence (AI) and robotics, and the mandated economic shift toward value-based care (VBC).

The European MedTech and HealthTech valuation landscape in October 2025 exhibits significant divergence by sub-sector, with a clear premium placed on innovative, high-growth, and recurring revenue business models, especially those powered by AI. Here is a breakdown of the valuation trends and multiples by sub-sector..